Stifel Financial
ABBV icon

Stifel Financial’s AbbVie ABBV Stock Holding History

Stifel Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-600
Closed -$36K – 2301
2014
Q4 		$36K Hold
600
– – ﹤0.01% 2233
2014
Q3 		$38K Buy
600
+200
+50% +$11.1K ﹤0.01% 2162
2014
Q2 		$21K Buy
+400
New +$21K ﹤0.01% 2175

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stifel Financial's ABBV Position: Q1 2026 in Review

Stifel Financial increased its AbbVie (ABBV) stake by 51% in Q1 2026, buying an estimated $280M and bringing the position to 3,732,204 shares worth $812M. The position accounts for 0.75% of the portfolio, ranked #19.

Stifel Financial first reported a position in ABBV in Q1 2014 and has held it in 49 quarters since. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Stifel Financial held 3,732,204 shares of AbbVie worth $812M as of Q1 2026.
  • Stifel Financial bought 1,264,508 AbbVie shares in Q1 2026, an estimated $280M.
  • AbbVie made up 0.75% of Stifel Financial's portfolio in Q1 2026, its #19 holding.
  • Stifel Financial first reported a position in AbbVie in Q1 2014 and has held it in 49 quarters since.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.